TY - JOUR
T1 - ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
AU - Doll, Sebastian
AU - Proneth, Bettina
AU - Tyurina, Yulia Y.
AU - Panzilius, Elena
AU - Kobayashi, Sho
AU - Ingold, Irina
AU - Irmler, Martin
AU - Beckers, Johannes
AU - Aichler, Michaela
AU - Walch, Axel
AU - Prokisch, Holger
AU - Trümbach, Dietrich
AU - Mao, Gaowei
AU - Qu, Feng
AU - Bayir, Hulya
AU - Füllekrug, Joachim
AU - Scheel, Christina H.
AU - Wurst, Wolfgang
AU - Schick, Joel A.
AU - Kagan, Valerian E.
AU - Angeli, José Pedro Friedmann
AU - Conrad, Marcus
N1 - Publisher Copyright:
© 2016 Nature America, Inc., part of Springer Nature. All rights reserved.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Ferroptosis is a form of regulated necrotic cell death controlled by glutathione peroxidase 4 (GPX4). At present, mechanisms that could predict sensitivity and/or resistance and that may be exploited to modulate ferroptosis are needed. We applied two independent approaches-a genome-wide CRISPR-based genetic screen and microarray analysis of ferroptosis-resistant cell lines-to uncover acyl-CoA synthetase long-chain family member 4 (ACSL4) as an essential component for ferroptosis execution. Specifically, Gpx4-Acsl4 double-knockout cells showed marked resistance to ferroptosis. Mechanistically, ACSL4 enriched cellular membranes with long polyunsaturated ω6 fatty acids. Moreover, ACSL4 was preferentially expressed in a panel of basal-like breast cancer cell lines and predicted their sensitivity to ferroptosis. Pharmacological targeting of ACSL4 with thiazolidinediones, a class of antidiabetic compound, ameliorated tissue demise in a mouse model of ferroptosis, suggesting that ACSL4 inhibition is a viable therapeutic approach to preventing ferroptosis-related diseases.
AB - Ferroptosis is a form of regulated necrotic cell death controlled by glutathione peroxidase 4 (GPX4). At present, mechanisms that could predict sensitivity and/or resistance and that may be exploited to modulate ferroptosis are needed. We applied two independent approaches-a genome-wide CRISPR-based genetic screen and microarray analysis of ferroptosis-resistant cell lines-to uncover acyl-CoA synthetase long-chain family member 4 (ACSL4) as an essential component for ferroptosis execution. Specifically, Gpx4-Acsl4 double-knockout cells showed marked resistance to ferroptosis. Mechanistically, ACSL4 enriched cellular membranes with long polyunsaturated ω6 fatty acids. Moreover, ACSL4 was preferentially expressed in a panel of basal-like breast cancer cell lines and predicted their sensitivity to ferroptosis. Pharmacological targeting of ACSL4 with thiazolidinediones, a class of antidiabetic compound, ameliorated tissue demise in a mouse model of ferroptosis, suggesting that ACSL4 inhibition is a viable therapeutic approach to preventing ferroptosis-related diseases.
UR - http://www.scopus.com/inward/record.url?scp=84995468814&partnerID=8YFLogxK
U2 - 10.1038/nchembio.2239
DO - 10.1038/nchembio.2239
M3 - Article
C2 - 27842070
AN - SCOPUS:84995468814
SN - 1552-4450
VL - 13
SP - 91
EP - 98
JO - Nature Chemical Biology
JF - Nature Chemical Biology
IS - 1
ER -